Objectives: The potential cardiovascular (CV) toxicity associated with combined antiretroviral therapy (cART) has been attributed mainly to the nucleoside reverse transcriptase inhibitors abacavir and didanosine. However, the other two components of cART-non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs)-may also be implicated, either directly or by influencing the action of the other drugs. This study evaluates the acute direct effects of the NNRTIs efavirenz and nevirapine and one of the most widely employed PIs, lopinavir, on leucocyte -endothelium interactions, a hallmark of CV disease.
Introduction
There is growing awareness of the chronic toxic effects induced by the lifelong administration of combined antiretroviral therapy (cART) to HIV-infected patients, particularly in relation to the cardiovascular (CV) diseases that accompany ageing. 1 cART involves the administration of at least three drugs: typically, two nucleoside reverse transcriptase inhibitors (NRTIs) plus either a non-nucleoside reverse transcriptase inhibitor (NNRTI) or a protease inhibitor (PI). 2, 3 Although CV toxicities have been attributed largely to the NRTI component of cART, in particular abacavir and didanosine, 4 -6 a role has also been proposed for NNRTIs and, especially, PIs. cells involves a sequential cascade of adhesive interactions between leucocytes and endothelial cells that begins with enhanced rolling and leads to the adhesion and subsequent endothelial transmigration of these white cells in a process mediated by the adhesion molecules present on both cell populations. 15, 16 The aim of the present study was to evaluate the direct effect of efavirenz in the early phases of responses after exposure: leucocyteendothelial cell interactions both in vitro and in vivo. We extended our analysis to include nevirapine, the other widely employed NNRTI, and lopinavir, a PI commonly used as an alternative to efavirenz in HIV therapy.
Materials and methods

Cell culture of human umbilical vein endothelial cells (HUVECs) and leucocyte isolation
HUVECs were harvested from freshly obtained umbilical cords as previously described, 17, 18 and passage 1 cells were subsequently employed in the experiments. Human peripheral blood polymorphonuclear (PMN) cells or peripheral blood mononuclear cells (PBMCs) were isolated from whole blood drawn from healthy volunteers and anticoagulated with sodium citrate. 5 Leucocytes and HUVECs were treated independently (4 h, 378C) with efavirenz (10-25 mM), nevirapine (10 -50 mM), lopinavir (10 -25 mM), control (without vehicle) or vehicle [efavirenz and lopinavir were dissolved in methanol and nevirapine in azide water (pH≤ 3)]. The aforementioned concentrations were employed because they mimic clinically relevant plasma levels. 12,19 -21 The Medical Ethics Committee of the Hospital Clinico Universitario de Valencia approved the study, and the experiments were conducted in accordance with the Declaration of Helsinki after obtaining the written informed consent of each participant.
Dynamic adhesion assay under flow conditions
The characteristics of the parallel-plate flow chamber model used in this study have been described previously. 6, 22 In brief, coverslips [coated with fibronectin (5 mg/mL)] containing confluent HUVEC monolayers were inserted in the chamber (378C) and a portion (5×25 mm) was exposed to the flow. The chamber was mounted on an inverted microscope (Nikon Eclipse TE 2000-S, ×40, Amstelveen, The Netherlands) with a video camera (Sony Exware HAD, Koeln, Germany). PMN cells or PBMCs were resuspended in Dulbecco's PBS with Ca 2+ and Mg 2+ buffer containing 20 mM HEPES and 0.1% human serum albumin at 1×10 6 or 0.5×10 6 cells/mL, respectively, and were drawn across the monolayer (flow rate 0.36 mL/min, shear stress 0.7 dyne/cm 2 ). Images of a single field were recorded for 5 min and leucocyte parameters were determined. Rolling flux was calculated by counting the number of cells rolling across 100 mm 2 of the monolayer during a 1 min period. The velocities of 20 consecutive leucocytes in the field of focus were determined by measuring the time required to travel 100 mm. Adhesion was determined after 5 min of perfusion by the analysis of 5-10 high-power (×40) fields. Leucocytes were considered to be adherent after 30 s of stable contact with the monolayer.
Flow cytometry
The expression of human leucocyte adhesion molecules was analysed in blood samples and that of endothelium molecules was quantified in confluent HUVECs. Blood samples and endothelial cells were treated (4 h, 378C) with the different antiretroviral drugs and then incubated with saturating amounts of the antibodies (20 min, 48C, in darkness). Subsequently, the samples were fixed and identified in a flow cytometer (FACScalibur Flow Cytometer, BD, Madrid, Spain). 23 
Intravital microscopy
Leucocyte-endothelial cell interactions were evaluated in fasted male Sprague-Dawley rats (200-250 g) following a standard experimental technique. 25, 26 In brief, rats were anaesthetized with sodium pentobarbital [65 mg/kg, intraperitoneally (ip)] and, following a midline abdominal incision, a segment of the mid-jejunum was exteriorized and placed on an optically clear viewing pedestal at 378C for tissue transillumination. The exposed mesentery was visualized using an orthostatic microscope (Nikon Optiphot-2, SMZ1, Nikon, Badhoevedor, The Netherlands) equipped with a ×20 objective lens (Nikon SLDW) and ×10 eyepieces, during which time it was continuously superfused with bicarbonate buffer saline (pH 7.4, 378C, 2 mL/min). A video camera (Sony SSC-C350P; Sony, Koeln, Germany) mounted on the microscope projected images onto a colour monitor (Sony Trinitron PVM-14N2E), and the images were captured on videotape (Sony SVT-S3000P) for playback analysis (final magnification of the video screen: ×1300). Single unbranched mesenteric venules were selected and their diameters (25 -40 mm) measured online using a video caliper (Microcirculation Research Institute, Texas A&M University, College Station, TX, USA). Centerline red blood cell velocity (V rbc ) was quantified online with an optical Doppler velocimeter (Microcirculation Research Institute). Blood flow and wall shear rate (g) were calculated as previously described, 27 and systemic arterial blood pressure was monitored. Numbers of rolling, adherent and emigrated leucocytes were determined offline during playback analysis of videotaped images. Rolling flux was assessed by counting the number of leucocytes passing a reference point in the vessel per minute. Leucocyte rolling velocity (V wbc ) was calculated by measuring the time required for these cells to travel along 100 mm of the venule and was expressed as mm/s. A leucocyte was considered to have adhered to the endothelium if it remained stationary for ≥30 s, and the numbers of these leucocytes were expressed per 100 mm of vessel. Leucocyte emigration was evaluated as the total number of interstitial leucocytes per field. In some cases, the area of the mesentery selected for the experiment was excised, fixed with paraformaldehyde (4% in PBS, pH 7.4) and stained with haematoxylin and eosin. The preparation was subsequently observed under a clear field microscope (×63), and the infiltrated leucocytes were counted (number per 2.5×10 24 cm 2 ) and classified morphologically as PMN leucocytes, macrophages and lymphocytes by an observer who was unaware of the treatment in question. 26 Animals were injected (2.5 mL, ip) with saline, vehicles (methanol or azide water) or one of the following antiretroviral drug solutions: efavirenz (10-25 mM, equivalent to 40 -100 mg/kg), nevirapine (10 -50 mM; 35 -165 mg/kg) or lopinavir (10 -25 mM; 80-200 mg/kg). Images (5 min period) were recorded 4 h later in order to allow enough time for the process of leucocyte emigration to initiate and were then evaluated by an observer who was blind to the treatment. The ip injection of drug solutions is a usual practice in intravital microscopy, 23,28 -30 as it allows longer incubation periods than superfusion 31 and is, thus, more suited to lengthy time-course studies such as the present one. All doses were representative of plasma concentrations in patients. 12,19 -21 Care was taken at each stage of the experiment to avoid any suffering of the animals. Procedures followed Spanish law concerning the use of experimental animals and were approved by the Ethics Committee of the Faculty of Medicine of the University of Valencia (Spain).
Functional role of adhesion molecules
This was assessed in both in vitro and in vivo settings by blocking the adhesion molecules with specific antibodies. For the in vitro experiments, Orden et al.
and prior to treatment with efavirenz, PMN cells and PBMCs were pre-treated with anti-lymphocyte function-associated antigen-1 (CD11a-LFA-1; 10 mg/ mL), anti-macrophage-1 antigen (CD11b-Mac-1; 20 mg/mL), anti-alpha-X integrin (CD11c-gp150,95; 10 mg/mL), anti-b 2 integrins (CD18; 10 mg/mL) or control antibodies (IgG1; 10 mg/mL) for 20 min at 48C in darkness. Prior to drug administration, HUVEC monolayers were pre-treated with antiintercellular adhesion molecule-1 (ICAM-1-CD54; 20 mg/mL) or control antibodies (IgG1; 10 mg/mL) for 30 min at 378C. The antibodies were assayed at previously described doses. 32 -35 For the in vivo experiments, antibodies were injected through the tail vein 30 min before efavirenz or nevirapine administration, as previously described, 36, 37 at doses that have been shown to block the in vivo function of the adhesion molecules analysed in the current study [2 mg/kg for WT-5 (anti-rat Mac-1, CD11b), and 1 mg/kg for WT-3 (anti-rat b 2 integrins, CD18) and for 1A29 (anti-rat ICAM-1, CD54)] or with control antibodies (2 mg/kg for IgA and 1 mg/kg for IgG1). 23, 38 To rule out a direct effect of the monoclonal antibodies (MAbs) on circulating leucocytes, portal blood samples were obtained and their number evaluated after the intravital measurements. 
Statistical analysis
One-way analysis of variance (ANOVA) with a Newman-Keuls post-test correction was employed for statistical analysis (mean+SEM, n≥4, P,0.05).
Results
Leucocyte -endothelial cell interactions
In human cells in vitro, efavirenz and nevirapine induced a decrease in rolling velocity (Figure 1a Figure 2d) . Interestingly, the effects of efavirenz on emigration were significantly stronger than those of nevirapine. Analysis of the haematoxylin-and eosin-stained mesenteric tissue confirmed these observations, revealing a significantly higher number of infiltrated leucocytes in efavirenz-treated animals (17.7+3.3 leucocytes per field versus 1.0+0.3 leucocytes per field in methanol-treated animals, P,0.01) than in the nevirapine group (6.0+0.4 leucocytes per field versus 0.7+0.3 leucocytes per field in azide water-treated animals, P,0.05), which were predominantly PMN leucocytes in both cases (Figure 3 ). Systemic haemodynamic parameters were not affected by any of the compounds evaluated (data not shown).
Role of adhesion molecules in NNRTI-induced leucocyte -endothelium interactions
Flow cytometry revealed that treatment with efavirenz significantly and dose-dependently augmented the expression of CD11b, CD11c and CD18 on both neutrophils and monocytes in human blood, while that of CD11a, CD49d and CD62L (L-selectin) was not affected (Table S1 , available as Supplementary data at JAC Online). Neither nevirapine nor lopinavir modified the expression of the adhesion molecules analysed on neutrophils or monocytes (Table S1 , available as Supplementary data at JAC Online). None of the assayed doses of efavirenz, nevirapine or lopinavir had any effect on the adhesion molecules of lymphocytes (data not shown) or human endothelial cells (Table S1 , available as Supplementary data at JAC Online).
The functional implication of adhesion molecules was assessed with specific antibodies. In vitro, the effects of efavirenz on interactions between human leucocytes (PMN cells or PBMCs) and the endothelium were completely reversed by blocking Mac-1 (CD11b), gp150,95 (CD11c), b 2 integrins (CD18) or their ligand ICAM-1 (CD54), but not by neutralizing LFA-1 (CD11a) (Figure 4 ). These in vitro results were confirmed in rat post-capillary venules in vivo; namely, the effects of efavirenz were not apparent when animals were pre-treated with antibodies against Mac-1 (CD11b), b 2 integrins (CD18) or ICAM-1 (CD54) ( Figure 5 ). However, the responses induced by nevirapine were not modified when animals were pre-treated with any of the abovementioned antibodies. Neither haemodynamic parameters nor systemic leucocyte count was affected by any of the antibodies employed (data not shown).
Discussion
This study shows that efavirenz, the most commonly employed NNRTI in HIV therapy, induces leucocyte recruitment through the interaction of certain b 2 integrins with ICAM-1. We obtained our results in two experimental models: (i) human cells in vitro; and (ii) rat mesenteric venules in vivo. The former is a dynamic experimental setting in which human leucocytes flow over a monolayer of HUVECs in a way that reproduces the rolling and adhesion processes that precede the formation of an inflammatory focus. 39, 40 The latter permits a more detailed analysis of the inflammatory outcome by evaluating the emigration of leucocytes from living vessels. 31, 41 A combination of the two experimental approaches allows for a more comprehensive analysis of the potentially proinflammatory vascular effects of drugs.
Concentrations of efavirenz (10-25 mM) or nevirapine (10-50 mM) mimicking those found in patients (3-13 and 10-25 mM, respectively) 12, 19, 20 induced human leucocyte (PMN or PBMC)-endothelial cell interactions in vitro. Although the functional effect of efavirenz on PBMC-endothelial cell interactions seemed to be weak, the expression of CD11b and CD11c molecules was particularly evident on monocytes, while almost absent in lymphocytes. 42 In our opinion this discrepancy results from the fact that, of the total population of PBMCs superfused through the flow chamber, only a small proportion were monocytes ( 10%); thus, their reactivity would be obscured by the 90% of lymphocytes that would not adhere to the endothelium due to their lack (both constitutively or after efavirenz incubation) of CD11b or CD11c. 42 Lopinavir (10-25 mM in our experiments; 7-17 mM in patients), 21 effect on any of the parameters evaluated. As a whole, these findings challenge previous perceptions of NNRTIs as relatively CV-friendly drugs and of PIs as potentially CV-toxic molecules.
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The results obtained in vitro were reproduced and expanded in the in vivo model; in addition to inducing leucocyte rolling and adhesion, both efavirenz and nevirapine (but not lopinavir) caused a significant emigration of white cells within post-capillary venules. This is of great relevance, as the movement of leucocytes towards inflamed tissue is considered the point of no return in the vascular inflammatory cascade, while the preceding phases (rolling and adhesion) are reversible. 44 The level of emigration induced by efavirenz was significantly higher than that produced by nevirapine (quantified by intravital microscopy and haematoxylin/eosin staining), which is compatible with the fact that nevirapine (and indeed lopinavir) had no effect on leucocytes or endothelial adhesion molecules. By contrast, efavirenz produced a selective up-regulation of the b 2 integrins Mac-1 (CD11b/CD18) and gp150,95 (CD11c/CD18) on neutrophils and monocytes, but not of the endothelial molecules E-selectin, ICAM-1 or VCAM-1.
When the functional implication of adhesion molecules was evaluated, the interactions induced by efavirenz were reversed by pre-treatment with antibodies against CD11b, CD18 or ICAM-1 (CD54), both in vitro and in vivo. The role of CD11c was evaluated in human cells only because of the unavailability of a commercially marketed rat antibody against this molecule. Our analysis of the role of adhesion molecules in the effects of efavirenz on the interplay between leucocytes and the endothelium strongly suggests that both b 2 integrins-gp150,95 (CD11c/CD18) and Mac-1 (CD11b/CD18)-interact with their endothelial ligand ICAM-1 (CD54). Although the involvement of CD11b and CD11c in adhesion and emigration would be expected, rolling was initially considered to be mediated by selectins and/or VLA-4/VCAM-1. 42 However, there is growing evidence that b 2 integrins also mediate leucocyte rolling in close dependence on their conformational state. 45, 46 b 2 Integrins (CD18) are cell adhesion receptors that share the same CD18 b chain but exhibit a distinctive a chain. The family includes four known types: aL (CD11a, LFA-1), aM (CD11b, Mac-1), aX (CD11c, gp95,150) and aD (CD11d). 42 The expression of CD11b and CD11c in lymphocytes is limited, but they are mobilized from intracellular secretory vesicles to the cell surface of neutrophils and monocytes within minutes of stimulation. 42 Their main ligand is ICAM-1, which is constitutivelyexpressed on the surface of the vascular endothelium. 42 CD11c has already been implicated in phagocytosis, antigen presentation by dendritic cells and the inflammatory response. 34 In addition to its role in mediating the adherence of neutrophils and monocytes to the vessel wall, Mac-1 (CD11b) has been proposed as a key link between cellular adhesion and thrombosis 47 by mediating the engagement of platelets. 48 The actions of nevirapine were not mediated by CD11b, CD11c or CD18, yet it did increase leucocyte rolling flux to a level similar to that induced by efavirenz while influencing less adhesion and particularly emigration. One possible explanation for this differential profile could be that nevirapine activates other families of adhesion molecules, such as P-selectin, which are implicated mainly in the rolling process. 42 Although the clinical translation of our results should be contemplated with caution, we believe they provide strong evidence that NNRTIs, and in particular efavirenz, alter leucocyte-endothelial interactions. As a whole, our findings point to an effect by which efavirenz activates leucocytes but not endothelial cells. This contrasts with reports suggesting that efavirenz-containing regimens are responsible for impaired endothelial function in patients, 9 or that, in vitro, this drug induces an increase in the levels of superoxide anions responsible for the endothelial damage and altered endothelial junctions that restrict vascular permeability. 12 Nevertheless, it should be pointed out that the period of exposure to efavirenz was substantially shorter in the present study than in the reports in question. Furthermore, since HIV infection is itself characterized by an increase in endothelial adhesion molecules, the profile of which (ICAM-1, VCAM-1 and E-selectin) 49 differs from that induced by efavirenz in our experiments, it is feasible that the effects of efavirenz and those of the virus are cumulative in patients. In other words, the virus may cause endothelial activation whereas efavirenz stimulates white cells. Given the increasing longevity of HIV-infected patients, and taking into account that CV illnesses are the most frequent cause of death among the non-HIV-infected ageing population, a potential relationship between the compounds used in cART and CV toxicity is of considerable importance. 
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